Objectives To evaluate the development and quality of actionable statements that qualify as
good practice statements (GPS) reported in COVID-19 guidelines. Design and setting …

Objective To appraise the availability, quality, and inclusivity of clinical guidelines produced
in the early stage of the coronavirus disease 2019 (covid-19) pandemic. Design Rapid …

Background The number of published clinical practice guidelines and recommendations
related to SARS-CoV-2 infections causing COVID-19 has rapidly increased. However …

Objectives To investigate how quickly evidence was incorporated into the Australian living
guidelines for COVID-19 during the first 12 months of the pandemic. Study Design and …

Abstract Background In December 2019, a novel coronavirus, severe acute respiratory
syndrome coronavirus 2 was identified as the cause of an acute respiratory disease …

Introduction Nearly every field of medicine has some form of clinical practice guidelines.
However, only within the past 5–10 years has the medical community acknowledged the …

What is new? Key findings: Despite clear scope, most guidelines for SARS CoV-2 infections
and for other care in the context of COVID-19 fell short of basic methodological standards …

Background. The coronavirus disease 2019 (COVID-19) pandemic has presented as a
therapeutic challenge for clinicians worldwide due to its rapid spread along with evolving …

Abstract Background and Objective To identify COVID-19 actionable statements (eg,
recommendations) focused on specific disadvantaged populations in the living map of …

Globally, considerable resources and community trust are invested in the development of
evidence-based guidelines for the prevention and treatment of a range of public health …